Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Enhancing Viral Detection and Surveillance with VirCapSeq-VERT

    Introduction to VirCapSeq-VERT
    The Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health has been at the forefront of developing innovative diagnostic technologies. In 2015, they introduced VirCapSeq-VERT, an advanced next-generation sequencing (NGS)-based system, enhancing the capabilities of pathogen detection. This system represents a significant advancement in the field of clinical diagnostics, particularly in the detection of viruses.

    The Technology Behind VirCapSeq-VERT
    Traditional diagnostic tools, such as PCR and antigen tests, are designed to identify specific, known pathogens. These targeted assays have been indispensable, especially evident during the COVID-19 pandemic. However, their reactive nature means they are typically available only after an outbreak has begun. In contrast, VirCapSeq-VERT offers a broad-range detection capability, encompassing both known and unknown viruses, with improved sensitivity and speed compared to other NGS platforms.

    Validation and Regulatory Approval
    The effectiveness of the latest edition of VirCapSeq-VERT was recently validated in a study published in the Journal of Clinical Microbiology. This validation was part of the regulatory application process in New York State, which approved VirCapSeq for the detection of nucleic acids of both DNA and RNA viruses in plasma and nasal swabs. The study involved thorough assessments of VirCapSeq's limit of detection, consistency, ability to identify mixed infections, and accuracy in clinical scenarios. Impressively, VirCapSeq-VERT achieved a clinical sensitivity of 99 percent and 100 percent clinical specificity.

    Broad Applications and Future Prospects
    Since its inception, VirCapSeq has been utilized globally in studies to investigate various outbreaks and for surveillance in humans, domestic animals, and wildlife. The technology has been accelerated through a partnership with the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. This collaboration aims to bolster U.S. preparedness for future outbreaks and enhance infectious disease diagnostics.

    Expert Opinions
    Vishal Kapoor, MS, Deputy Director for Laboratory Medicine at the CII, emphasized the uniqueness of VirCapSeq. “VirCapSeq is the only sequencing technology with regulatory approvals that has the broad range coverage of unbiased high throughput sequencing with significantly greater sensitivity in the detection and identification of all vertebrate viruses, including new and emerging species,” he stated. Kapoor further highlighted the potential of VirCapSeq in early identification of viral threats, which could be crucial in containing outbreaks and preventing pandemics.

    Echoing this sentiment, W. Ian Lipkin, MD, John Snow Professor of Epidemiology and CII Director, pointed out the transformative potential of VirCapSeq in precision medicine. “Our technology is poised to transform precision medicine, giving caregivers the ability to quickly pinpoint the cause of an infection so as to guide treatment,” Lipkin said. He also emphasized the public health benefits of the technology, providing vital information on circulating viruses in communities.

Latest Articles

Collapse

  • seqadmin
    Best Practices for Single-Cell Sequencing Analysis
    by seqadmin



    While isolating and preparing single cells for sequencing was historically the bottleneck, recent technological advancements have shifted the challenge to data analysis. This highlights the rapidly evolving nature of single-cell sequencing. The inherent complexity of single-cell analysis has intensified with the surge in data volume and the incorporation of diverse and more complex datasets. This article explores the challenges in analysis, examines common pitfalls, offers...
    06-06-2024, 07:15 AM
  • seqadmin
    Latest Developments in Precision Medicine
    by seqadmin



    Technological advances have led to drastic improvements in the field of precision medicine, enabling more personalized approaches to treatment. This article explores four leading groups that are overcoming many of the challenges of genomic profiling and precision medicine through their innovative platforms and technologies.

    Somatic Genomics
    “We have such a tremendous amount of genetic diversity that exists within each of us, and not just between us as individuals,”...
    05-24-2024, 01:16 PM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, Today, 02:20 PM
0 responses
9 views
0 likes
Last Post seqadmin  
Started by seqadmin, 06-07-2024, 06:58 AM
0 responses
181 views
0 likes
Last Post seqadmin  
Started by seqadmin, 06-06-2024, 08:18 AM
0 responses
228 views
0 likes
Last Post seqadmin  
Started by seqadmin, 06-06-2024, 08:04 AM
0 responses
184 views
0 likes
Last Post seqadmin  
Working...
X